SpaceXs Starship Central to Valuation Early Investor Suggests Frontier Markets Await Salesforce Reports Earnings and Revenue Beat But FullYear Outlook Disappoints Asphalts Heat Island Effect Pushes Cities Toward Pavement Revolution Starbucks Discontinues AI Inventory Management Program Across North America Shein Acquires Sustainable Brand Everlane in FastFashion Shakeup Meta Settles Landmark Social Media Addiction Lawsuit with US School District Winmark Corporation Q1 2026 Earnings EPS Falls Short of Expectations as Shares Edge Higher NXPI Q1 2026 Earnings EPS Beat Drives Stock Jump WES Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency NVCR Q1 2026 Earnings EPS Miss of 1852 Sends Shares Down Nearly 7 RANI Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues BIVI Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Drops MUC Sees Modest Uptick as Muni Bond Market Regains Footing Fortress Biotech Preferred Shares FBIOP Gain 237 as Price Approaches Key Resistance GameStop GME Holds Steady Near Support as Trading Volume Remains Subdued Home Federal Bancorp HFBL Posts 242 Gain as Shares Test Resistance Near 2048 TMUSL Holds Steady Near Flat as Bond Market Digests Steady Yields Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales RBLX Q1 2026 Earnings EPS Beats Estimates Significantly Stock Rises on Narrower Loss Cypherpunk Technologies CYPH Slides 8 Can Support at 101 Hold CrossAmerica Partners LP CAPL Q1 2026 Earnings Massive EPS Surprise Drives Modest Stock Uptick Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD BCTX Q1 2026 Earnings EPS Surprise Beats Estimates Yet Stock Slips 618 CNC Q1 2026 Earnings Robust EPS Surprise Drives Stock Higher Certara Inc CERT Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Solid Operational Progress WEBTOON Entertainment WBTN Q1 2026 Earnings EPS Beat Driven by Cost Controls Amid Revenue Uncertainty BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline